---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-21-032854"
form_type: "8-K"
ticker: "IMNN"
cik: "0000749647"
company_name: "Imunon, Inc."
filed_at: "2021-12-30T23:59:59+00:00"
generated_at: "2026-06-27T21:49:05.285875+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.25
calibrated_materiality_score: 0.25
confidence: "high"
source: SEC EDGAR
---

# Celsion director Andreas Voss retires from board effective Dec 31, 2021

## Summary
- Dr. Andreas Voss, a Class III director, will retire from the Board effective December 31, 2021.
- Voss served on the Science & Technology Committee and as a strategic advisor to the CEO during 2020-2021.
- He will continue as Managing Director of Celsion GmbH, a wholly owned subsidiary, focusing on strategy and management.
- Retirement is due to time demands of the subsidiary role, not disagreement with management or the Board.

## SEC filing metadata
- accession: 0001493152-21-032854
- form_type: 8-K
- ticker: IMNN
- cik: 0000749647
- company_name: Imunon, Inc.
- filed_at: 2021-12-30T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.25
- calibrated_materiality_score: 0.25
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/749647/000149315221032854/0001493152-21-032854-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/749647/000149315221032854/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-21-032854
- JSON: https://secwatch.observer/filing/0001493152-21-032854.json
- Plain text: https://secwatch.observer/filing/0001493152-21-032854.txt

## Key facts
- Executive change
  Andreas Voss retired as Director at Imunon, Inc..
  - Action: retired
  - Role: Director
  source text: Dr. Andreas Voss, a Class III member of the Board of Directors (the “Board”) will retire from the Company’s Board effective December 31, 2021.
  evidence_url: https://www.sec.gov/Archives/edgar/data/749647/000149315221032854/0001493152-21-032854-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.